Mutation Status, Journal of Clinical Oncology, vol.29, issue.15, pp.292011-2019, 2011. ,
DOI : 10.1200/JCO.2010.33.5091
Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab, Journal of Clinical Oncology, vol.26, issue.3, pp.374-379, 2008. ,
DOI : 10.1200/JCO.2007.12.5906
Gefitinib or Chemotherapy for Non???Small-Cell Lung Cancer with Mutated EGFR, New England Journal of Medicine, vol.362, issue.25, pp.3622380-2388, 2010. ,
DOI : 10.1056/NEJMoa0909530
BRIM-3 Study Group: Improved survival with vemurafenib in melanoma with BRAF V600E mutation, N Engl J Med, issue.26, pp.3642507-2516, 2011. ,
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer, New England Journal of Medicine, vol.353, issue.16, pp.3531673-84, 2005. ,
DOI : 10.1056/NEJMoa052122
Testing by Local, Central, and Reference Laboratories in Specimens From the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial, Journal of Clinical Oncology, vol.24, issue.19, pp.243032-243040, 2006. ,
DOI : 10.1200/JCO.2005.03.4744
Targeted Therapy, Journal of Clinical Oncology, vol.29, issue.31, pp.294168-74, 2011. ,
DOI : 10.1200/JCO.2011.36.0107
Survival in BRAF V600???Mutant Advanced Melanoma Treated with Vemurafenib, New England Journal of Medicine, vol.366, issue.8, pp.366707-366721 ,
DOI : 10.1056/NEJMoa1112302
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial, The Lancet, vol.380, issue.9839, pp.380358-65 ,
DOI : 10.1016/S0140-6736(12)60868-X
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma, New England Journal of Medicine, vol.367, issue.2, pp.107-121 ,
DOI : 10.1056/NEJMoa1203421
Tumour molecular profiling for deciding therapy???the French initiative, Nature Reviews Clinical Oncology, vol.456, issue.8, pp.479-86 ,
DOI : 10.1038/nrclinonc.2012.42
Prognostic value of BRAF(V 600 ) mutations in melanoma patients after resection of metastatic lymph nodes, Ann Surg Oncol, vol.2012, issue.13, pp.194314-194335 ,
Detection of BRAF p.V600E Mutations in Melanomas, The Journal of Molecular Diagnostics, vol.15, issue.1, pp.94-100 ,
DOI : 10.1016/j.jmoldx.2012.09.001
Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples, Experimental and Molecular Pathology, vol.92, issue.3, pp.92275-80 ,
DOI : 10.1016/j.yexmp.2012.03.001
Performance and Cost Efficiency of KRAS Mutation Testing for Metastatic Colorectal Cancer in Routine Diagnosis: The MOKAECM Study, a Nationwide Experience, PLoS ONE, vol.12, issue.7, p.68945, 2013. ,
DOI : 10.1371/journal.pone.0068945.s002
URL : https://hal.archives-ouvertes.fr/hal-00974911
Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalinfixed , paraffin-embedded tissue specimens of malignant melanoma, Arch Pathol Lab Med, vol.2012, issue.11, pp.1361385-91 ,
Reducing Sequence Artifacts in Amplicon-Based Massively Parallel Sequencing of Formalin-Fixed Paraffin-Embedded DNA by Enzymatic Depletion of Uracil-Containing Templates, Clinical Chemistry, vol.59, issue.9, pp.1376-83, 2013. ,
DOI : 10.1373/clinchem.2012.202390